Total Liabilities Summary of Biohit Oyj

Biohit Oyj's latest annual total liabilities in 2023 was 3.5 Million EUR , down -1.6% from previous year.
Biohit Oyj's latest quarterly total liabilities in 2024 Q1 was 3.4 Million EUR , down -2.86% from previous quarter.
Biohit Oyj reported annual total liabilities of 3.55 Million EUR in 2022, up 53.78% from previous year.
Biohit Oyj reported annual total liabilities of 2.31 Million EUR in 2021, up 11.52% from previous year.
Biohit Oyj reported quarterly total liabilities of 3.4 Million EUR for 2024 Q1, down -2.86% from previous quarter.
Biohit Oyj reported quarterly total liabilities of 3.49 Million EUR for 2023 Q3, down -0.17% from previous quarter.

Annual Total Liabilities Chart of Biohit Oyj (2023 - 2004)

Historical Annual Total Liabilities of Biohit Oyj (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	3.5 Million EUR	-1.6%
2022	3.55 Million EUR	53.78%
2021	2.31 Million EUR	11.52%
2020	2.07 Million EUR	-25.72%
2019	2.79 Million EUR	39.95%
2018	1.99 Million EUR	20.76%
2017	1.65 Million EUR	-26.22%
2016	2.23 Million EUR	57.9%
2015	1.41 Million EUR	-22.56%
2014	1.83 Million EUR	-68.71%
2013	5.85 Million EUR	29.61%
2012	4.51 Million EUR	-75.76%
2011	18.62 Million EUR	13.71%
2010	16.38 Million EUR	11.81%
2009	14.65 Million EUR	0.24%
2008	14.61 Million EUR	-5.69%
2007	15.49 Million EUR	11.44%
2006	13.9 Million EUR	2.24%
2005	13.6 Million EUR	57.78%
2004	8.62 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.4 Million EUR	0.0%
2024 Q1	3.4 Million EUR	-2.86%
2023 Q3	3.49 Million EUR	-0.17%
2023 FY	3.5 Million EUR	-1.6%
2023 Q2	3.5 Million EUR	0.0%
2023 Q4	3.5 Million EUR	0.17%
2023 Q1	3.5 Million EUR	-1.6%
2022 Q4	3.55 Million EUR	0.0%
2022 FY	3.55 Million EUR	53.78%
2022 Q3	3.55 Million EUR	1.63%
2022 Q2	3.5 Million EUR	0.0%
2022 Q1	3.5 Million EUR	51.32%
2021 Q3	2.31 Million EUR	10.14%
2021 Q2	2.1 Million EUR	0.0%
2021 Q1	2.1 Million EUR	1.25%
2021 FY	2.31 Million EUR	11.52%
2021 Q4	2.31 Million EUR	0.0%
2020 Q1	2.2 Million EUR	-21.2%
2020 Q2	2.2 Million EUR	0.0%
2020 Q3	2.07 Million EUR	-5.73%
2020 Q4	2.07 Million EUR	0.0%
2020 FY	2.07 Million EUR	-25.72%
2019 Q2	2.6 Million EUR	0.0%
2019 FY	2.79 Million EUR	39.95%
2019 Q1	2.6 Million EUR	30.33%
2019 Q4	2.79 Million EUR	0.0%
2019 Q3	2.79 Million EUR	7.38%
2018 Q2	2 Million EUR	0.0%
2018 Q3	1.99 Million EUR	-0.25%
2018 FY	1.99 Million EUR	20.76%
2018 Q1	2 Million EUR	21.07%
2018 Q4	1.99 Million EUR	0.0%
2017 Q3	1.65 Million EUR	-21.33%
2017 FY	1.65 Million EUR	-26.22%
2017 Q2	2.1 Million EUR	0.0%
2017 Q4	1.65 Million EUR	0.0%
2017 Q1	2.1 Million EUR	-6.21%
2016 Q4	2.23 Million EUR	22.89%
2016 Q1	1.6 Million EUR	12.83%
2016 Q2	1.9 Million EUR	18.75%
2016 Q3	1.82 Million EUR	-4.11%
2016 FY	2.23 Million EUR	57.9%
2015 Q2	2.1 Million EUR	31.25%
2015 Q1	1.6 Million EUR	-12.62%
2015 FY	1.41 Million EUR	-22.56%
2015 Q4	1.41 Million EUR	-11.38%
2015 Q3	1.6 Million EUR	-23.81%
2014 Q3	2.6 Million EUR	0.0%
2014 FY	1.83 Million EUR	-68.71%
2014 Q4	1.83 Million EUR	-29.58%
2014 Q2	2.6 Million EUR	4.0%
2014 Q1	2.5 Million EUR	-57.28%
2013 Q1	4.6 Million EUR	1.88%
2013 Q3	5.6 Million EUR	-8.2%
2013 Q4	5.85 Million EUR	4.5%
2013 Q2	6.1 Million EUR	32.61%
2013 FY	5.85 Million EUR	29.61%
2012 Q4	4.51 Million EUR	-1.85%
2012 Q2	5 Million EUR	-57.26%
2012 FY	4.51 Million EUR	-75.76%
2012 Q3	4.6 Million EUR	-8.0%
2012 Q1	11.7 Million EUR	-37.18%
2011 Q1	17.1 Million EUR	4.4%
2011 Q3	18.2 Million EUR	-3.19%
2011 Q2	18.8 Million EUR	9.94%
2011 Q4	18.62 Million EUR	2.34%
2011 FY	18.62 Million EUR	13.71%
2010 Q1	16.1 Million EUR	9.9%
2010 Q2	16.5 Million EUR	2.48%
2010 FY	16.38 Million EUR	11.81%
2010 Q3	16.3 Million EUR	-1.21%
2010 Q4	16.38 Million EUR	0.49%
2009 Q4	14.65 Million EUR	0.0%
2009 FY	14.65 Million EUR	0.24%
2008 FY	14.61 Million EUR	-5.69%
2007 FY	15.49 Million EUR	11.44%
2006 FY	13.9 Million EUR	2.24%
2005 FY	13.6 Million EUR	57.78%
2004 FY	8.62 Million EUR	0.0%

Peer Total Liabilities Comparison of Biohit Oyj

Name	Total Liabilities	Total Liabilities Difference
Herantis Pharma Oyj	2.01 Million EUR	-73.329%
Nanoform Finland Oyj	11.18 Million EUR	68.717%

Global Stocks Search

Biohit Oyj (BIOBV.HE)

Total Liabilities Summary of Biohit Oyj

Annual Total Liabilities Chart of Biohit Oyj (2023 - 2004)

Historical Annual Total Liabilities of Biohit Oyj (2023 - 2004)

Peer Total Liabilities Comparison of Biohit Oyj